Search This Blog

Wednesday, May 8, 2019

Bio-Rad reports Q1 EPS $1.65, consensus $1.10

Reports Q1 revenue $554.0M, consensus $549.56M. “We are encouraged by our overall performance for the first quarter, which reflects continued strength in many of our product areas across most geographies. Improvements in our core operating performance during the quarter provide us with good momentum as we head into the rest of the year,” said CEO Norman Schwartz.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.